When diagnosed early, cancer survival rates increase more than fourfold; yet, current tools detect few cancers and often only after the disease has progressed. Many of today’s tests are out of reach for most people. What if we could test for numerous cancers at an early stage and use the results to prevent further tumor development and inform therapeutic interventions? What if that testing was accessible to everyone? At Harbinger Health, we are bringing together unique insights into the biology of cancer’s origin with artificial intelligence and the latest genetic screening technologies to meet the challenge of finding cancer at its inception.